Corentin Richard
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Biological Psychiatry top 2%
Papers in
- Oncology 38
- Cancer Immunotherapy and Biomarkers 19
- Colorectal Cancer Treatments and Studies 6
- Pancreatic and Hepatic Oncology Research 6
-
- Cancer Genomics and Diagnostics 15
- Co-authors
- François Ghiringhelli (22 shared papers)Emeric Limagne (11 shared papers)Bertrand Routy (14 shared papers)Romain Boidot (26 shared papers)Arielle Elkrief (12 shared papers)Marion Thibaudin (3 shared papers)Caroline Truntzer (5 shared papers)Bruno P. Coudert (5 shared papers)
- Journals
- OncoImmunology (6 papers)Nature Medicine (6 papers)Nature (6 papers)Nature Communications (5 papers)Science (3 papers)
- Partner nations
- FranceCanadaUnited Kingdom
In The Last Decade
Corentin Richard
93 papers receiving 10.2k citations
Corentin Richard's Hit Papers
Peers
Comparison fields: 5 of 145
- Oncology 4.1k
- Biological Psychiatry 291
- Immunology 1.8k
- Cancer Research 954
- Molecular Biology 4.6k
Countries citing papers authored by Corentin Richard
This map shows the geographic impact of Corentin Richard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corentin Richard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corentin Richard more than expected).
Fields of papers citing papers by Corentin Richard
This network shows the impact of papers produced by Corentin Richard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corentin Richard. The network helps show where Corentin Richard may publish in the future.
Co-authors
The 25 scholars most cited alongside Corentin Richard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 98 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors Hit paper breakdown → | 2017 | 4482 |
| 2 | Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer Hit paper breakdown → | 2022 | 536 |
| 3 | Lung adenocarcinoma promotion by air pollutants Hit paper breakdown → | 2023 | 528 |
| 4 | Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial Hit paper breakdown → | 2023 | 378 |
| 5 | Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage Hit paper breakdown → | 2020 | 325 |
| 6 | 2020 | 258 | |
| 7 | Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA Hit paper breakdown → | 2023 | 255 |
| 8 | A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti–PD-1 Resistance through Effects on the Gut Microbiota Hit paper breakdown → | 2022 | 203 |
| 9 | The evolution of lung cancer and impact of subclonal selection in TRACERx Hit paper breakdown → | 2023 | 188 |
| 10 | 2019 | 182 | |
| 11 | 2020 | 170 | |
| 12 | 2019 | 169 | |
| 13 | A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers Hit paper breakdown → | 2023 | 169 |
| 14 | 2019 | 160 | |
| 15 | The evolution of non-small cell lung cancer metastases in TRACERx Hit paper breakdown → | 2023 | 154 |
| 16 | 2018 | 153 | |
| 17 | 2021 | 148 | |
| 18 | 2023 | 138 | |
| 19 | 2017 | 98 | |
| 20 | 2018 | 83 |
About Corentin Richard
Corentin Richard is a scholar working on Oncology, Cancer Research, Immunology, Pulmonary and Respiratory Medicine and Virology, having authored 98 papers that have together received 10.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (19 papers), Cancer Genomics and Diagnostics (15 papers), Gut microbiota and health (9 papers), Immune Cell Function and Interaction (9 papers), Lung Cancer Treatments and Mutations (7 papers), Colorectal Cancer Treatments and Studies (6 papers), RNA modifications and cancer (6 papers) and Pancreatic and Hepatic Oncology Research (6 papers). The work is most often cited by research in Oncology (4.1k citations), Biological Psychiatry (291 citations), Immunology (1.8k citations), Cancer Research (954 citations) and Molecular Biology (4.6k citations). Corentin Richard has collaborated with scholars based in France, Canada and United Kingdom. Frequent co-authors include François Ghiringhelli, Emeric Limagne, Bertrand Routy, Romain Boidot, Arielle Elkrief, Marion Thibaudin, Caroline Truntzer, Bruno P. Coudert, Meriem Messaoudene and Aurélie Lagrange. Their work appears in journals such as OncoImmunology, Nature Medicine, Nature, Nature Communications and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.